ADVERTISEMENT
ADVERTISEMENT
Genetic Sequencing Uncovers New Options for Multiple Myeloma Patients
Genetic Sequencing Uncovers New Options for Multiple Myeloma Patients
A small pilot study suggests the approach can identify effective treatments already approved for other cancers.
Genetic Sequencing Uncovers New Options for Multiple Myeloma Patients
Genetic Sequencing Uncovers New Options for Multiple Myeloma Patients

A small pilot study suggests the approach can identify effective treatments already approved for other cancers.

A small pilot study suggests the approach can identify effective treatments already approved for other cancers.

combination therapy
Drug Cocktail Slows Progress of Aggressive Breast Cancer
Ashley P. Taylor | Oct 22, 2018 | 2 min read
Checkpoint inhibition combined with chemotherapy gives patients with triple-negative metastatic breast cancer about two months more time without significant tumor growth, a study finds.
Two Experimental Drugs Reduce Infections in the Elderly
Sukanya Charuchandra | Jul 12, 2018 | 2 min read
Despite the treatment being given for only six weeks, the positive effects lasted for a year.
Immune Therapy Improves Lung Cancer Patients’ Survival
Jim Daley | Apr 16, 2018 | 2 min read
Pembrolizumab combined with chemotherapy nearly doubles survival rates and shrinks tumors in some individuals.
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
Vicki Brower | Apr 1, 2018 | 9 min read
With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.
FDA Approves Clinical Trials to Test Cuban Cancer Vaccine
Bob Grant | Oct 31, 2016 | 2 min read
An early-stage study of the effectiveness of a lung-cancer vaccine developed by scientists in Cuba could start as early as next month.
Chemotherapy Pioneer Dies
Dan Cossins | May 6, 2013 | 1 min read
Emil Frei III, a cancer researcher who in the 1950s combined multiple chemotherapy drugs to treat childhood leukemia, has died at the age of 89.
Tuberculosis Trial Launched
Hannah Waters | Mar 20, 2012 | 1 min read
The TB Alliance will test a new combination of drugs to combat normal and multi-drug-resistant tuberculosis.
ADVERTISEMENT